Ukrainian Institute of international education and Jintai Academy of Arts signed a memorandum of cooperation on traditional Chinese medicine industry in China Belarus Industrial Park

发布于: 2021-02-27 00:00


On February 26, Liu Yudan, chairman of the board of directors of Ukrainian International College, visited Zhongbai Industrial Park and held a symposium with Yan Gang, general manager of the park development company, and Cai Chuanqing, President of Jintai Academy of culture, on cooperation in traditional Chinese medicine R & D and higher education in the park.



The symposium discussed the possibility of cooperation between China Belarus Industrial Park and Ukrainian Institute of International Education in the fields of traditional Chinese medicine, education and big data. General manager Yan Gang said that as an international industrial cooperation platform, the industrial chain of China Belarus Industrial Park is constantly improving. He is glad to have the opportunity to attract cooperative enterprises such as Ukrainian Institute of international education to invest in China Belarus industrial park after the Chinese medicine industry settled in the park. He hopes to carry out in-depth cooperation in many fields such as Chinese medicine, culture and education in the future. After the talks, in the presence of Wang Yuhang, general manager of CAMCE international and Yan Gang, general manager of Zhongbai Industrial Park Development Company, Jintai Academy of culture, which is about to settle in the park, signed a memorandum of intent with Ukrainian Institute of international education. According to the memorandum, the two sides will jointly promote the development of traditional Chinese medicine and higher vocational education industry in Zhongbai Industrial Park.



Karojev, the first deputy general manager of the development company, Ren Fei, deputy general manager and other leaders attended the event.



Source: Official Website of China Belarus Industrial Park,, people' and the official website of the Ministry of Commerce


Recommended articles

  • 2021-11-11
      The world's first proprietary Chinese medicine for the treatment of COVID-19 has been released   Zhou Xingting   Yao jian   "Linglan Pesticide-clear" is developed and produced by New Times Biotechnology Co., LTD., a Traditional Chinese medicine enterprise in China-Belarus Industrial Park.     The world's first effective Chinese patent medicine for COVID-19 treatment   Southern Guangdong introduced "linglan epidemic qing" registered sales in Australia    On November 5, on the occasion of the opening of the China International Import Expo, the press conference on Traditional Chinese medicine products of the China-Belarus Industrial Park and the signing ceremony of the cooperation agreement of the China-Belarus Industrial Park jointly hosted by the Belarusian Embassy in China, chin...
  • 2021-11-10
      On January 5, Qingfu Capsule, the world's first pure herbal medicine for COVID-19, was jointly developed by China and Belarus and launched in Shanghai. The drug will be produced in the China-Belarus Industrial Park on the outskirts of Minsk, Belarus.   China-belarus Industrial Park Chinese medicine enterprise new era biological medicine company qingfu capsule launch ceremony     Qingfu Capsule is a pure natural plant extract capsule developed and produced by Dr. CAI Chuanqing of Jintai Cultural Institute of China using modern technology combined with traditional medical essence, which can effectively treat and prevent COVID-19. Since February 2020, Linglan granules have successfully cured COVID-19 patients in many countries, including former Ukrainian Prime Minister Yulia Tymoshenko and president Petro Poros...
  • 2021-11-10
      On November 5, when the China International Import Expo opened, the China-Belarus Industrial Park held a press conference on Traditional Chinese medicine products of the Industrial Park and the signing ceremony of the cooperation agreement between the industrial park, demonstrating the major achievements of china-Belarus anti-epidemic cooperation.     According to reports, qingfu capsule series, originated from the classic formula in Treatises on Typhoid fever 1800 years ago, combined with the successful experience of Traditional Chinese medicine in fighting malignant infectious diseases such as The Outbreak of Blast, combined with modern medicine, in view of novel coronavirus characteristics of rapid transmission, rapid disease progression, high mortality and many sequelae, is a new formula. Novel Coronavirus can effectively inhibit novel Coronavirus, redu...